000 01273 a2200361 4500
005 20250512195751.0
264 0 _c19821216
008 198212s 0 0 eng d
022 _a0031-7012
024 7 _a10.1159/000137730
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFregnan, G B
245 0 0 _aAppearance of extrapyramidal symptoms: interaction between neuroleptics and other CNS active drugs.
_h[electronic resource]
260 _bPharmacology
_c1982
300 _a102-10 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aAtropine
_xpharmacology
650 0 4 _aAutonomic Agents
_xpharmacology
650 0 4 _aBasal Ganglia Diseases
_xchemically induced
650 0 4 _aCentral Nervous System Agents
_xpharmacology
650 0 4 _aFemale
650 0 4 _aHistamine H1 Antagonists
_xpharmacology
650 0 4 _aMotor Skills
_xdrug effects
650 0 4 _aPilocarpine
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aSerotonin Antagonists
_xpharmacology
700 1 _aVidali, M
773 0 _tPharmacology
_gvol. 25
_gno. 2
_gp. 102-10
856 4 0 _uhttps://doi.org/10.1159/000137730
_zAvailable from publisher's website
999 _c6127812
_d6127812